Clinical Trials Browser

Phase 3 × Interventional × 6-acetylaminocaproic acid × Clear all

NCT06434753 2024-06-04

Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease.

Phase 3 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal